SynthesisThe Lancet. Oncology2022

5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).

Shankar Siva et al.PubMed ↗Publisher ↗

No numbers read from the abstract.